Phase II Results of Antigenics' Oncophage Cancer Vaccine in Colorectal Cancer Featured in Clinical Cancer Research.
Business Wire › August 19, 2003
Linked as:
Extract
Phase II Results of Antigenics' Oncophage Cancer Vaccine in Colorectal Cancer Featured in Clinical Cancer Research.
Business Editors/Health/Medical Writers
BIOWIRE2K NEW YORK--(BUSINESS WIRE)--Aug. 19, 2003 Two-Year Survival Rate of 100 Percent in Subjects Who Responded Immunologically to Oncophage(R) Antigenics Inc. (NASDAQ: AGEN), the world leader in heat shock protein technology, announced today that resu...See the full content of this document
Sponsored links
